This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

Specifically, the team tested whether mRNA technology could be used to protect against the damage inflicted by the venom of ...

With data centers consuming record electricity, SMRs or small modular reactors are emerging as a possible clean-power ...

The same mRNA technology used in COVID-19 vaccines may offer a powerful new way to prevent long-term muscle damage caused by ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The Pfizer-developed vaccine was found to be 34.5 percent more effective than ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The results, published Nov. 19 in The New England Journal of Medicine, suggest that ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The Pfizer flu vaccine uses the same type of messenger RNA science that was used in the ...

Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. The ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...

A scientist in the French city of Orleans holds up a test tube containing messenger RNA Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...